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Studies have suggested a possible role of polycyclic aromatic hydrocarbons (PAHs) in the
etiology of esophageal cancer in Golestan Province, Iran, where incidence of this cancer is
very high. In order to investigate the patterns of non-smoking related exposure to PAHs in
Golestan, we conducted a cross-sectional study collecting questionnaire data, genotyping
polymorphisms related to PAH metabolism, and measuring levels of 1-hydroxypyrene glu-
curonide (1-OHPG), a PAH metabolite, in urine samples collected in two seasons from the
same group of 111 randomly selected never-smoking women. Beta-coefﬁcients for corre-
lations between 1-OHPG as dependent variable and other variables were calculated using
linear regression models. The creatinine-adjusted 1-OHPG levels in both winter and sum-
mer samples were approximately 110μmol/molCr (P for seasonal difference= 0.40). In
winter, red meat intake (β= 0.208; P= 0.03), processed meat intake (β= 0.218; P= 0.02),
and GSTT1-02 polymorphism (“null” genotype: β= 0.228; P= 0.02) showed associations
with 1-OHPG levels, while CYP1B1-07 polymorphism (GG versus AA+GA genotypes:
β= –0.256; P= 0.008) showed an inverse association. In summer, making bread at home
(> weekly versus never: β= 0.203; P= 0.04), second-hand smoke (exposure to ≥3 ciga-
rettes versus no exposure: β= 0.254; P= 0.01), andGSTM1-02 “null” genotype (β= 0.198;
P= 0.04) showed associations with 1-OHPG levels, but GSTP1-02 polymorphism (CT+TT
versus CC: β= –0.218; P= 0.03) showed an inverse association. This study conﬁrms high
exposure of the general population in Golestan to PAHs and suggests that certain foods,
cooking methods, and genetic polymorphisms increase exposure to PAHs.
Keywords: 1-hydroxypyrene glucuronide, esophageal cancer, frying, red meat, polycyclic aromatic hydrocarbon,
polymorphism
INTRODUCTION
Polycyclic aromatic hydrocarbons (PAHs) are by-products of
incomplete combustion of organic matter and occur as mixtures
of complex and variable composition. The major sources of PAHs
are tobacco smoking, some occupational exposures (such as coke
oven working), air pollution, and diet, particularly charbroiled
or fried foods (Unwin et al., 2006; Perello et al., 2008; Kamangar
et al., 2009). The International Agency for Research on Cancer
has classiﬁed benzo[a]pyrene, a prototype PAH, and exposures in
several occupations with heavy exposure to PAHs as carcinogenic
to humans (Baan et al., 2009). Consistent associations between
those occupational exposures and cancers of the lung and skin
have been shown in epidemiological studies, and strong mecha-
nistic evidence and carcinogenicity in several animal species has
been reported for benzo[a]pyrene (Baan et al., 2009). An associa-
tion between PAHs and urinary bladder has also been reported in
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several studies (Bosetti et al., 2007). Factors such as the route of
exposure, the chemical compositionof themixture, the presence of
co-exposures, and genetic susceptibility are likely to explain inter-
organ differences in the carcinogenicity of PAH (IARC Working
Group, 2010).
Cross-sectional studies in high-incidence areas of esophageal
squamous cell carcinoma (ESCC) in Linxian (China) andGolestan
Province (Iran) indicate that the inhabitants of these areas are
highly exposed to PAHs (Roth et al., 1998a,b, 2001; Wornat
et al., 2001; Kamangar et al., 2005; Islami et al., 2009b). The
hypothesis of a carcinogenic role of PAH on the esophageal
mucosa is supported by experimental and epidemiological stud-
ies, including those showing an increased risk of ESCC among
chimney sweeps (Hogstedt et al., 1982; Evanoff et al., 1993) and
tobacco smokers (Hecht, 2003). We have recently reported in a
case–control study in Golestan Province higher levels of anti-
bodies against benzo[a]pyrene diol epoxide-I-modiﬁed guano-
sine in non-tumoral esophageal biopsies from patients with
biopsy-proven ESCC than in biopsies from control subjects
(Abedi-Ardekani et al., 2010).
In Golestan Province, where both ESCC rates and exposure to
PAHs are high, the sources of exposure toPAHs arenotwell charac-
terized.High PAHexposure levels (compared to several other pop-
ulations; see Discussion) in Golestan have been observed among
non-smokers as well as smokers, and only 15% of the variance
in PAH levels in urine was accounted for by known factors, such
as age, sex, place of residence (rural versus urban), and tobacco
use (Kamangar et al., 2005). We conducted an exploratory mol-
ecular epidemiological study on healthy, never-smoking female
inhabitants of Golestan Province to investigate the patterns of
exposure to PAHs, sources of PAHs other than tobacco smoking,
and the association of several lifestyle and genetic factors with 1-
hydroxypyrene glucuronide (1-OHPG) levels in urine. 1-OHPG is
a stable PAH metabolite that reﬂects recent (within the past 24 h)
exposure to mixed PAHs (Roth et al., 2001). The half-life for uri-
nary excretion of 1-OHPG ranges from 6 to 35 h and peak urine
concentration occurs a few hours following exposure (Strickland
et al., 1996).
MATERIALS AND METHODS
STUDY SUBJECTS
For this study, 111 participants in the Golestan Cohort Study were
randomly selected. The Golestan Cohort Study is a prospective
study that recruited 50,045 participants, 40–75 years of age, from
eastern parts of Golestan Province between January 2004 and
June 2008, with 40,013 participants from 326 villages and 10,032
from urban areas (Pourshams et al., 2010). In order to investigate
sources of PAHs other than tobacco smoking, speciﬁcally poten-
tial exposure from cooking methods, only never-smoking women
were enrolled in this study because preparation of food in the
area is usually done by women, so they might provide more pre-
cise information about food consumption and cooking methods.
Furthermore, smoking among women in Golestan is uncommon;
therefore, erroneous assignment of tobacco use is less likely among
women. Also, if exposure to PAHs is to be a major cause of ESCC
in Golestan, this should be true in both men and women, as inci-
dence of ESCC is high in both sexes. The age adjusted incidence
rates (ASR) for ESCC in men and women in Golestan are 43 and
36 per 105 person-years, respectively (Semnani et al., 2006), with
higher rates in eastern than in western parts of the province (Mah-
boubi et al., 1973). The overall ASR for esophageal cancer among
men and women in the more developed areas of the world is 6.5
and 1.2 per 105 person-years, respectively; the respective rates in
the less developed areas are 11.8 and 5.7 (Jemal et al., 2011). An
earlier study did not show any difference by sex in 1-OHPG levels
in urine samples in Golestan (Kamangar et al., 2005).
DATA AND BIOLOGICAL SAMPLE COLLECTION
Data and biological sample collection from all participants took
place in two rounds: one from December 2006 to January 2007
(hereafter referred to as the winter round) and the other from
August to early September 2007 (the summer round). In thewinter
round, information on demographic characteristics and duration
of using a heating system (in hours) during the previous 24-h
and the fuel used for heating was collected from all participants.
All food and beverage items consumed the previous day were
recorded on an open questionnaire. Height and weight of partici-
pants were also measured by trained research staff. Questionnaire
data on exposure to second-hand smoke and cooking practicewere
collected in both rounds. We asked questions about exposure to
second-hand smoke in general and over the previous 24 h, and in
case of any exposure, the numbers of cigarettes of second-hand
smoke per day was recorded. We asked study participant whether
they did cooking in general and over the previous 24-h, and when
the reply was positive, cooking frequency was recorded. We also
collected data on cooking methods in the household, including
frying, boiling, baking, and barbecuing in general (and not over
the previous 24 h), as well as frying intensity, which was assessed
by questioning the change in foods’ color caused by frying. For
this, we proposed four options: no frying, little change in color,
becoming golden, and becoming brown or darkening. For our
analyses, the ﬁrst two categories were considered as no/little frying
and the third and fourth categories were combined and considered
as high-temperature frying.
In order to obtain repeated urine samples in two seasons, in
both winter and summer rounds a single spot urine sample was
collected from each participant and stored at −20˚C. In the winter
round, 10ml of peripheral venous blood was collected in EDTA
containing tubes. Buffy coat containing white blood cells were
obtained and stored at −70˚C until genotyping. All biological
samples were collected in mornings or early afternoons during
weekdays. In both seasons, questionnaire data and biological sam-
ples were collected from each participant on the same day. The
study was reviewed and approved by the Institutional Review
Board of the Digestive Disease Research Center of Tehran Univer-
sity of Medical Sciences. Informed written consent was obtained
from all participants.
LABORATORY ASSESSMENTS
Details of the laboratory assessments are available in the Section
“Appendix.” Brieﬂy, 1-OHPG concentration was measured in 4.5-
ml spot urine specimens at the Department of Environmental
Health Sciences, Johns Hopkins Bloomberg School of Public
Health, Baltimore, United States, using the assay developed by
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Strickland et al. (1994). This was done with synchronous ﬂuo-
rescence spectroscopy (Perkin Elmer LS50B Luminescence spec-
trometer, Norwalk, CT, USA) using a wavelength difference of
34 nm between excitation and emission. The limit of detection
was 0.01 ng 1-OHPG/ml urine and the recovery of the assay was
95–100%. Fourteen control samples were used to assess the relia-
bility of 1-OHPG measurements. With the mean of 5.74 pmol/ml
(SD: 0.64), the coefﬁcient of variation was 11.1%.
Genotyping was performed at the Department of Health Risk
Analysis and Toxicology, Maastricht University, Maastricht, the
Netherlands. Genetic variants including single nucleotide poly-
morphisms (SNPs) or deletions in the following genes were
determined: genes for phase Imetabolizing enzymesmyeloperoxi-
dase (MPO) and cytochromes P450s (CYP1A1,CYP1A2,CYP1B1,
CYP2E1, and CYP3A4) and for phase II metabolizing enzymes
glutathione S-transferases (GSTM1, GSTP1, GSTT1), and N -
acetyltransferase 2 (NAT2). Details of the primer development
are available elsewhere (Knaapen et al., 2004; Ketelslegers et al.,
2006). Genotyping was performed by the single base extension
(SBE)method using SnaPShot (Applied Biosystems,Nieuwerkerk,
a.d. Ijssel, the Netherlands), and primer 3 and Netprimer software
were used to design SBE primers (Knaapen et al., 2004; Ketel-
slegers et al., 2006; Langie et al., 2010). Finally, the samples were
analyzed on an ABI Prism 3100 genetic analyser using Genescan
Analysis software. Polymerase chain reaction (PCR) primers were
designed using Primer 3 and Netprimer software. More detailed
information about the studied genetic variants and genotyping is
presented in the Section “Appendix.”
STATISTICAL ANALYSIS
Food recall data over theprevious 24 hwere transformed to speciﬁc
food group intake values. Intake of food groups was categorized
into two groups, as below median and equal to or above median.
When medians included zero, the intakes were categorized as no
intake and any intake. Intake of red meat (≥ median versus <
median) showed an association with 1-OHPG level in preliminary
analyses, so it was examined in further analyses as a continuous
variable (log-transformed), as well as a categorical variable with
three groups. Nearly half of the participants did not consume red
meat over the previous 24 h, so they were included in one group
and those who ate red meat were categorized in two equal-sized
groups according to their intake. For the continuous variable, a
constant value of 0.1 was added to red meat intake values before
log-transformation.
The normality of the 1-OHPG variable distributions was
assessed by histograms and the Shapiro–Wilk W test, and
the distributions were found to be severely skewed. With log-
transformation, the distribution became normal, so we used log-
transformed 1-OHPG values in all further analyses. Creatinine
(Cr)-adjusted 1-OHPG levels inwinter and summer samples, from
participants with paired samples only (n = 106), were compared
using paired t -tests. Linear regressionmodels were used to investi-
gate the association between Cr-adjusted 1-OHPG level and vari-
ables of interest. Categorical results from genotyping were treated
as follows: the wild-type homozygote group was categorized as the
reference genotype and coded as 0 (zero), the heterozygote group
was coded as 1, and the homozygote variant group was coded as
2. Results from the summer round were adjusted for age (contin-
uous), place of residence (urban; rural), ethnicity (non-Turkmen;
Turkmen), body mass index (BMI, kg/m2, log-transformed), and
frequency of second-hand smoke exposure over the previous 24 h
(none; 1–2; ≥3 cigarettes/day). Results from the winter round
were additionally adjusted for red meat (none; 1–24; ≥25) and
processedmeat (no use, some use) consumption over the previous
24 h. For all linear regression models, we report regression coefﬁ-
cients and P-values (two-sided) to illustrate the associations. For
categorical variables with more than two categories, P-values for
trend were obtained from adjusted regressionmodels by assigning
consecutive numbers to categories within each variable.
RESULTS
1-OHPG LEVELS, OVERALL AND IN ASSOCIATION WITH DEMOGRAPHIC
FACTORS AND BODY MASS INDEX
Table 1 shows median levels of 1-OHPG and creatinine, and
median and 25th and 75th percentiles of Cr-adjusted 1-OHPG
in urine samples by demographic characteristics. 1-OHPG lev-
els in urine were obtained for 108 participants in winter and
109 participants in summer. Overall, the median 1-OHPG level
in summer was 2.5-fold higher than the median level in winter.
On the other hand, the creatinine levels in summer were approx-
imately twice as high as in winter, indicating that urine samples
collected in winter weremore diluted than the summer urine sam-
ples. Therefore, the Cr-adjusted 1-OHPG level did not show a
seasonal difference (P = 0.40); levels in both winter and summer
samples were approximately 110μmol/molCr. For each of the cat-
egories of demographic variables, Cr-adjusted 1-OHPG levels in
summer and winter were not signiﬁcantly different. Cr-adjusted
1-OHPG levels in the urban area seemed to be the same in summer
and winter (0.110 and 0.111μmol/molCr, respectively; P = 0.68).
The median level in rural areas changed from 0.105μmol/molCr
in winter to 0.136μmol/molCr in summer (P = 0.46). Approxi-
mately 68% of participants used natural gas for heating in winter;
32% used kerosene. There was no association between 1-OHPG
levels in urine and fuels used for heating or duration of using
heating systems over the previous 24 h (data not shown).
There was no major variation in Cr-adjusted 1-OHPG lev-
els by different categories of age, place of residence, ethnicity,
and education (Table 2). There was an association between Cr-
adjusted 1-OHPG in winter and BMI (P for trend= 0.03), but the
association was disappeared after adjustments for other factors.
Cr-adjusted 1-OHPG level in summer was not associated with
BMI.
1-OHPG LEVELS AND FOOD INTAKE
Food intake data were available only for the winter round of the
study. Table 3 shows the relation between Cr-adjusted 1-OHPG
levels in urine and intake of selected food groups over the previous
24 h. Intake of red meat and processed meat were associated with
1-OHPG levels. Regression coefﬁcient was 0.208 (P = 0.03) for red
meat and 0.218 (P = 0.02) for processed meat consumption; how-
ever, only 2.9% of participants consumed processed meat over the
previous 24 h. Regression coefﬁcient for intake of fat was –0.191
(P = 0.06). The coefﬁcients for other food groups were smaller
than the above values.
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Table 1 | Creatinine and 1-OHPG levels in urine in relation to demographic characteristicsa.
Demographic
characteristics
Winter Summer P for
No. (%) Median
1-OHPG
Median
Cr
Median Cr-adjusted
1-OHPG (p25, p75)
Median
1-OHPG
Median
Cr
Median Cr-adjusted
1-OHPG (p25, p75)
seasonal diff.b
All participants 111 (100) 1.03 121.2 0.107 (0.057, 0.166) 2.54 243.7 0.113 (0.047, 0.242) 0.40
AGE
< Median (48 years) 54 (48.6) 1.19 127.9 0.109 (0.062, 0.151) 2.73 241.1 0.125 (0.049, 0.256) 0.33
≥ Median 57 (51.4) 0.90 96.9 0.099 (0.054, 0.205) 2.16 243.7 0.092 (0.046, 0.219) 0.80
PLACE OF RESIDENCE
Urban 44 (39.6) 1.24 128.1 0.110 (0.058, 1.171) 2.16 234.8 0.111 (0.047, 0.228) 0.68
Rural 67 (60.4) 0.98 97.0 0.105 (0.056, 0.161) 2.70 246.8 0.136 (0.046, 0.254) 0.46
ETHNICITY
Non-Turkmen 24 (21.6) 0.91 158.4 0.080 (0.045, 0.136) 1.63 223.7 0.086 (0.043, 0.179) 0.67
Turkmen 87 (78.4) 1.11 102.7 0.118 (0.062, 0.182) 2.79 255.6 0.133 (0.049, 0.243) 0.47
EDUCATION
No school 78 (70.3) 1.03 102.1 0.114 (0.059, 0.195) 2.70 246.8 0.128 (0.047, 0.248) 0.43
Some school 33 (29.7) 1.11 162.9 0.087 (0.054, 0.149) 2.16 233.6 0.086 (0.050, 0.200) 0.75
a1-OHPG levels in urine were obtained from 108 participants in winter and 109 participants in summer.The biomarker levels are presented in following units: 1-OHPG,
pmol/ml; creatinine, mg/dl; creatinine-adjusted 1-OHPG, μmol/molCr.
bP-value for difference in Cr-adjusted 1-OHPG levels in winter and summer (in logarithmic scale), calculated using paired t-tests.The number of participant with paired
results was 106.
1-OHPG, 1-hydroxypyrene glucuronide; Cr, creatinine.
Table 2 | Crude and adjusted beta-coefficients and P -values for the association of demographic characteristics and body mass index with
creatinine-adjusted 1-hydroxypyrene glucuronide levels in urinea.
Characteristics Winter Summer
Crude β P Adjusted β 1 P Adjusted β 2 P Crude β P Adjusted β 1 P
Age, yearsb −0.040 0.68 −0.048 0.63 −0.112 0.26 −0.055 0.57 −0.062 0.52
PLACE OF RESIDENCE
Urban Reference – Reference – Reference – Reference – Reference –
Rural −0.035 0.72 −0.121 0.29 −0.111 0.32 0.034 0.73 −0.037 0.74
ETHNICITY
Non-Turkmen Reference – Reference – Reference – Reference – Reference –
Turkmen 0.084 0.39 0.137 0.25 0.115 0.32 0.077 0.43 0.098 0.38
EDUCATION
No school Reference – Reference – Reference – Reference – Reference –
Some school −0.021 0.83 −0.029 0.82 0.032 0.79 −0.060 0.53 −0.089 0.45
Body mass index (kg/m2)b 0.213 0.03 0.132 0.20 0.130 0.19 −0.037 0.70 −0.006 0.96
aBeta-coefﬁcients and P-values come from linear regression models, in which Cr-adjusted 1-OHPG level was in logarithmic scale. Adjusted β 1: results were adjusted
for other variables listed in the table and frequency of second-hand smoke exposure over the previous 24 h (none; 1–2; ≥3 cigarettes/day) in the respective season.
Adjusted β 2: results from winter were additionally adjusted for red meat (none; 1–24; ≥25g) and processed meat (no use, any use) consumption over the previous
24 h.
bMean (SD).
1-OHPG LEVELS AND SECOND-HAND SMOKING
Exposure to second-hand tobacco smoke from three or more
cigarettes over the previous 24 h compared to those who were
not exposed to tobacco smoke (Table 4) was associated with
increased levels of 1-OHPG; this was stronger in summer
(β= 0.254; P = 0.008) than in winter (β= 0.156; P = 0.12).
The coefﬁcient for the correlation between 1-OHPG levels
and exposure to second-hand smoke from one or two ciga-
rettes was –0.019 in winter (P = 0.86) and –0.152 in summer
(P = 0.13)
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Table 3 | Crude and adjusted beta-coefficients and P -values for the association between intake of selected food groups (over the previous 24h)
and creatinine-adjusted 1-OHPG levels in urine in wintera.
Food group intake No. (%) Median (p25, p75) Crude β P -value Adjusted β P -value
RED MEAT
Categorical
None 51 (48.6) 0.082 (0.046, 0.150) Reference – Reference
1–24 g 27 (25.7) 0.082 (0.058, 0.152) 0.069 0.50 0.116 0.26
≥25g 27 (25.7) 0.148 (0.099, 0.310) 0.257 0.01 0.249 0.02
P for trend 0.02 0.02
Continuous – – 0.206 0.04 0.208 0.03
PROCESSED MEAT
No intake 102 (97.1) 0.105 (0.058, 0.152) Reference – Reference
Any intake 3 (2.9) 0.326 (0.311, 0.550) 0.222 0.02 0.218 0.02
CHICKEN
No intake 62 (59.1) 0.098 (0.064, 0.161) Reference – Reference
Any intake 43 (40.9) 0.118 (0.048, 0.205) 0.009 0.92 0.103 0.31
FISH
No intake 100 (95.2) 0.110 (0.062, 0.166) Reference – Reference
Any intake 5 (4.8) 0.073 (0.046, 0.099) −0.080 0.42 −0.144 0.14
MEAT (ANY KIND)b
0–12 g (1st quartile) 28 (26.7) 0.082 (0.060, 0.152) Reference – Reference
13–28 g 27 (25.7) 0.080 (0.039, 0.135) 0.000 1.00 −0.015 0.90
29–49 g 25 (23.8) 0.135 (0.105, 0.207) 0.237 0.05 0.149 0.23
≥50g 25 (23.8) 0.109 (0.062, 0.188) 0.104 0.21 −0.019 0.88
P for trend 0.14 0.85
EGG
No intake 72 (68.6) 0.109 (0.057, 0.174) Reference – Reference –
Any intake 33 (31.4) 0.105 (0.064, 0.151) 0.000 1.00 −0.016 0.87
DAIRY PRODUCTS
<Median (120 g) 52 (49.5) 0.110 (0.063, 0.151) Reference – Reference –
≥ Median 53 (50.5) 0.105 (0.051, 0.210) 0.021 0.84 0.020 0.84
FAT, OIL
< Median (32 g) 52 (49.5) 0.123 (0.065, 0.206) Reference – Reference –
≥ Median 53 (50.5) 0.097 (0.046, 0.144) −0.137 0.16 −0.191 0.06
BREAD
< Median (240 g) 50 (47.6) 0.129 (0.056, 0.210) Reference – Reference –
≥ Median 55 (52.4) 0.097 (0.064, 0.150) −0.055 0.58 −0.006 0.95
RICE
< Median (110 g) 52 (49.5) 0.109 (0.067, 0.150) Reference – Reference –
≥ Median 53 (50.5) 0.099 (0.054, 0.188) −0.028 0.76 −0.071 0.48
PASTA
No intake 90 (85.7) 0.110 (0.063, 0.154) Reference – Reference –
Any intake 15 (14.3) 0.080 (0.036, 0.210) −0.064 0.52 −0.065 0.50
OTHER CEREALS
No intake 89 (84.8) 0.109 (0.063, 0.171) Reference – Reference –
Any intake 16 (15.2) 0.095 (0.054, 0.147) −0.040 0.68 −0.020 0.84
CEREALS (ANY KIND)
< Median (396 g) 49 (46.7) 0.105 (0.063, 0.188) Reference – Reference –
≥ Median 56 (53.3) 0.109 (0.058, 0.152) −0.053 0.59 −0.036 0.72
LEGUMES
< Median (50 g) 60 (57.1) 0.114 (0.066, 0.165) Reference – Reference –
≥ Median 45 (42.9) 0.094 (0.044, 0.161) −0.104 0.29 −0.098 0.32
(continued)
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Table 3 | continued
Food group intake No. (%) Median (p25, p75) Crude β P -value Adjusted β P -value
VEGETABLES
< Median (93 g) 52 (49.5) 0.107 (0.060, 0.174) Reference – Reference –
≥ Median 53 (50.5) 0.109 (0.062, 0.152) 0.027 0.79 −0.051 0.61
FRUIT
No intake 61 (58.1) 0.131 (0.067, 0.207) Reference – Reference –
Any intake 44 (41.9) 0.085 (0.050, 0.138) −0.077 0.44 −0.061 0.53
DRIED FRUIT
No intake 86 (81.9) 0.110 (0.062, 0.161) Reference – Reference –
Any intake 19 (18.1) 0.091 (0.039, 0.210) −0.078 0.43 0.044 0.66
PICKLES
No intake 83 (79.0) 0.113 (0.058, 0.152) Reference – Reference –
Any intake 22 (30.0) 0.078 (0.063, 0.210) −0.037 0.71 −0.108 0.28
SWEETS, SWEET DRINKS
< Median (48 g) 54 (51.4) 0.116 (0.069, 0.171) Reference – Reference –
≥ Median 51 (48.6) 0.105 (0.044, 0.152) −0.071 0.47 −0.045 0.65
aMedian and 25th and 75th percentiles of 1-OHPG are presented in μmol/molCr. Beta-coefﬁcients and P-values come from linear regression models, in which
creatinine-adjusted 1-OHPG level in logarithmic scale was the dependent variable. Adjusted models included age (continuous), place of residence (urban; rural),
ethnicity (non-Turkmen; Turkmen), body mass index (kg/m2, logarithmic scale), frequency of exposure to second-hand smoke over the previous 24 h (none; 1–2;
≥3 cigarettes/day) and red meat (none; 1–24; ≥25g) and processed meat (no use, any use) consumption over the previous 24 h.
bIncluding red meat, processed meat, chicken, and ﬁsh.
1-OHPG, 1-hydroxypyrene glucuronide; Cr, creatinine.
1-OHPG LEVELS AND COOKING PRACTICES
Table 4 also shows the relation between Cr-adjusted 1-OHPG lev-
els in urine,making bread at home and the intensity of food frying.
Making bread at homemore thanonce aweek in summerwas asso-
ciated with increased 1-OHPG (β= 0.203; P = 0.04); P for trend
was 0.04. Such an association was not observed in winter. With
regard to frying intensity, the strongest positive correlations were
observed with high-temperature frying of red meat (β= 0.144;
P = 0.15) and onion (β= 0.126; P = 0.20) in winter. There was
an inverse association between high-temperature frying of vegeta-
bles and 1-OHPG levels in summer (β= –0.223; P = 0.03). There
was no association between 1-OHPG level in urine and several
other variables related to food preparing (data not shown), includ-
ing cooking over the previous day or regular cooking in general,
cooking rice, boiling the food groups presented in Table 4, and
fuels used for baking bread or preparing foods. Nearly all of the
participants used natural gas for baking or cooking.Whereas high-
temperature frying was a common cooking practice (Table 4),
barbecuing was uncommon and had no association with 1-OHPG
levels (data not shown).
1-OHPG LEVELS AND GENOTYPES
Table 5 shows the distribution of the studied genotypes, P-value
for Hardy–Weinberg equilibrium for each gene, and the relation
between Cr-adjusted 1-OHPG levels in winter and the genotypes.
A few genes were not in Hardy–Weinberg equilibrium; none of
them had an association with 1-OHPG levels. The pattern of asso-
ciation were generally different in the winter and summer rounds.
However, relatively consistent results were found for the GT+TT
(versus GG) genotypes of CYP2E1-05, which showed fairly strong
inverse association with 1-OHPG levels in winter (β= –0.176;
P = 0.07) and summer (β= –0.184; P = 0.07). In winter, the“null”
genotypeofGSTT1-02 was associatedwith increased 1-OHPG lev-
els (β= 0.228; P = 0.02), while there were inverse associations for
GG genotype (versus AA+GA genotypes) of CYP1B1-07 (β= –
0.256; P = 0.008). In summer, the CT+TT genotype of GSTP1-02
(β= –0.218; P = 0.03) showed an inverse and the “null” genotype
of GSTM1-02 (β= 0.198; P = 0.04) showed a positive association
with 1-OHPG levels.
DISCUSSION
This study showed similar levels of a urinary biomarker of PAH
exposure in summer and winter. Red and processed meat intake
and GSTT1-02 polymorphism showed correlations with 1-OHPG
levels in winter, while CYP1B1-07 polymorphism had an inverse
correlation. In summer, making bread at home, second-hand
smoke, and GSTM1-02 polymorphism were correlated with 1-
OHPG levels, but GSTP1-02 polymorphism showed an inverse
association; food intake data were not available for this season.
Participants in the current study, who were all female non-
smokers, had higher 1-OHPG levels compared to non-smokers
without occupational exposure to PAHs in several other stud-
ies that used the same methodology as this study for assessing
1-OHPG; in fact, the levels in this study were comparable to
those of smokers in the other studies (Table 6). The higher SD
for Cr-adjusted 1-OHPG levels in the current study suggests that
inter-individual variability is larger in our study participants than
in other populations. Almost all of the participants in the cur-
rent study used natural gas or kerosene for heating in winter. The
similarity of the Cr-adjusted 1-OHPG levels in summer and win-
ter implies that exposure to PAHs through heating in winter does
not have a major effect on total exposure in Golestan. As we used
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Table 4 | Crude and adjusted Beta-coefficients and P -values for the association of second-hand smoke exposure (over the previous 24h), frying
intensity, and several genetic factors with creatinine-adjusted 1-hydroxypyrene glucuronide levels in urinea.
Characteristics Winter Summer
No. (%) Crude β P Adjusted
β 1
P Adjusted
β 2
P No. (%) Crude β P Adjusted
β 1
P
SECOND-HAND SMOKE
None 80 (72.1) Reference – Reference – Reference – 84 (75.7) Reference – Reference
1–2 cigarettes/day 18 (16.2) −0.034 0.73 −0.019 0.86 −0.029 0.78 13 (11.7) −0.140 0.13 −0.152 0.13
≥ 3 cigarettes/day 13 (11.7) 0.115 0.13 0.132 0.19 0.156 0.12 14 (12.6) 0.264 0.005 0.254 0.008
P for trend 0.24 0.28 0.21 0.05 0.05
MAKING BREADAT HOME
No 63 (59.4) Reference – Reference – Reference – 79 (72.5) Reference – Reference –
Yes 43 (40.6) 0.121 0.22 0.084 0.41 0.053 0.59 30 (27.5) 0.182 0.06 0.178 0.07
<Weekly 19 (17.9) 0.107 0.29 0.024 0.82 0.063 0.55 16 (14.7) −0.029 0.76 −0.017 0.57
Once/week 11 (10.4) 0.014 0.89 −0.004 0.97 −0.054 0.59 7 (6.4) 0.123 0.20 0.121 0.21
> Once/week 13 (12.3) 0.121 0.23 0.125 0.59 0.080 0.44 9 (8.3) 0.203 0.04 0.203 0.04
P for trend 0.25 0.21 0.58 0.03 0.04
FRYING INTENSITY
Red meat
No/little frying 33 (31.1) Reference – Reference – Reference – 63 (57.8) Reference – Reference –
High-temperature frying 73 (68.8) 0.149 0.13 0.187 0.07 0.144 0.15 46 (42.2) 0.108 0.27 0.087 0.39
Chicken
No/little frying 19 (17.9) Reference – Reference – Reference – 21 (19.3) Reference – Reference –
High-temperature frying 87 (82.1) −0.095 0.33 −0.107 0.30 −0.081 0.42 88 (80.7) −0.017 0.86 −0.082 0.44
Onion
No/little frying 15 (14.1) Reference – Reference – Reference – 21 (19.3) Reference – Reference –
High-temperature frying 91 (85.9) 0.101 0.30 0.126 0.21 0.126 0.20 88 (80.7) 0.016 0.65 0.016 0.88
Vegetables
No/little frying 76 (71.7) Reference – Reference – Reference – 61 (56.0) Reference – Reference –
High-temperature frying 30 (28.3) −0.018 0.86 0.023 0.81 0.023 0.81 48 (44.0) −0.219 0.02 −0.223 0.03
Fish
No/little frying 22 (20.7) Reference – Reference – Reference – 55 (50.5) Reference – Reference –
High-temperature frying 84 (79.3) 0.152 0.12 0.006 0.95 0.097 0.33 54 (49.5) −0.004 0.97 −0.032 0.75
Potato
No/little frying 31 (29.2) Reference – Reference – Reference – 27 (24.8) Reference – Reference –
High-temperature frying 75 (70.8) −0.024 0.81 −0.041 0.69 −0.055 0.57 82 (75.2) −0.024 0.80 −0.049 0.62
Eggplant
No/little frying 14 (13.2) Reference – Reference – Reference – 17 (15.9) Reference – Reference –
High-temperature frying 92 (86.8) −0.027 0.78 −0.066 0.52 −0.051 0.61 90 (84.1) −0.096 0.32 −0.151 0.14
aBeta-coefﬁcients and P-values come from linear regression models, in which creatinine (Cr)-adjusted 1-OHPG level in logarithmic scale was the dependent variable.
Adjusted β 1: results were adjusted for age (continuous), place of residence (urban; rural), ethnicity (non-Turkmen; Turkmen), body mass index (kg/m2, logarithmic
scale), and frequency of exposure to second-hand smoke over the previous 24 h (none; 1–2; ≥3 cigarettes/day) in the respective season. Adjusted β 2: results from
winter were additionally adjusted for red meat (none; 1–24; ≥25g) and processed meat (no use, any use) consumption over the previous 24-h.
paired t -tests, any substantial overall intra-individual variability
in the two seasons is unlikely. In concordance with this ﬁnding,
the fuels used for heating and the duration of their use did not
show any association with 1-OHPG levels.
Diet seems to be the main source of PAHs among non-smokers
who do not have occupational exposure to those compounds
in studies from other regions of the world (Straif et al., 2005).
However, information on the role of diet in exposure to PAHs in
Golestan is limited.Only two earlier studies inGolestanhave inves-
tigated such association. These studies assessed the PAH levels in
commonly eaten foods and in bread and rice (the twomajor staple
foods in the region), but they did not ﬁnd high levels on average
(Joint Iran-IARC Study Group, 1977; Hakami et al., 2008). In one
of those studies, however,when the daily intake of benzo[a]pyrene
was estimated from its levels in cooked rice, bread, and drinking
water, the daily intake of the compound in Golestan was higher
than in a low-risk area in Iran (Hakami et al., 2008). In the current
study, participants were questioned about the frying intensity of
the consumed food in general rather than over the previous 24 h.
1-OHPG levels in urine reﬂect recent exposure (within hours) to
www.frontiersin.org February 2012 | Volume 2 | Article 14 | 7
Islami et al. Exposure to PAHs in Golestan, Iran
Ta
b
le
5
|P
-v
al
u
es
fo
r
H
ar
d
y–
W
ei
n
b
er
g
eq
u
ili
b
ri
u
m
an
d
cr
u
d
e
an
d
ad
ju
st
ed
B
et
a-
co
ef
fi
ci
en
ts
an
d
P
-v
al
u
es
fo
r
th
e
as
so
ci
at
io
n
b
et
w
ee
n
p
o
ly
m
o
rp
h
is
m
s
in
se
ve
ra
lp
h
as
e
Ia
n
d
p
h
as
e
II
m
et
ab
o
liz
in
g
en
zy
m
e
ge
n
es
an
d
cr
ea
ti
n
in
e-
ad
ju
st
ed
1-
hy
d
ro
xy
py
re
n
e
g
lu
cu
ro
n
id
e
le
ve
ls
in
u
ri
n
ea
.
Po
ly
m
o
rp
h
is
m
b
G
en
o
ty
p
e
N
o.
(%
)
P
W
in
te
r,
b
et
a-
co
ef
fi
ci
en
ts
S
u
m
m
er
,b
et
a-
co
ef
fi
ci
en
ts
fo
r
H
W
E
C
ru
d
e
β
P
-v
al
u
e
A
d
ju
st
ed
β
1
P
-v
al
u
e
A
d
ju
st
ed
β
2
P
-v
al
u
e
C
ru
d
e
β
P
-v
al
u
e
A
d
ju
st
ed
β
1
P
-v
al
u
e
P
H
A
S
E
IE
N
Z
Y
M
E
S
C
Y
P
1A
1-
01
A
A
90
(8
4.
1)
0.
37
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
10
48
94
3
G
A
17
(1
5.
9)
0.
17
5
0.
07
0.
14
1
0.
16
0.
06
0.
55
−0
.0
39
0.
7
−0
.0
44
0.
65
C
Y
P
1A
1-
03
C
C
97
(9
1.
5)
0.
65
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
17
99
81
4
C
A
9
(8
.5
)
−0
.1
6
0.
11
−0
.1
76
0.
08
−0
.1
77
0.
07
0.
07
9
0.
43
0.
09
1
0.
35
C
Y
P
1A
2-
03
C
C
24
(2
2.
2)
<
0.
00
1
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
76
25
51
C
A
41
(3
8.
0)
0.
08
2
0.
52
0.
07
4
0.
56
0.
01
9
0.
88
−0
.0
62
0.
63
−0
.0
01
0.
99
A
A
43
(3
9.
8)
0.
08
4
0.
51
0.
11
1
0.
38
0.
06
5
0.
6
0.
07
8
0.
54
0.
12
1
0.
33
C
Y
P
1B
1-
05
C
C
58
(5
4.
2)
0.
01
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
10
56
83
6
G
C
41
(3
8.
0)
−0
.0
05
0.
96
0.
02
5
0.
96
0.
02
5
0.
81
0.
07
4
0.
46
0.
11
0.
28
G
G
9
(8
.4
)
0.
01
3
0.
9
0.
00
5
0.
96
−0
.0
11
0.
91
−0
.1
68
0.
1
−0
.1
29
0.
2
C
Y
P
1B
1-
07
A
A
70
(6
6.
0)
0.
07
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
18
00
44
0
G
A
31
(2
9.
3)
−0
.1
29
0.
18
−0
.1
02
0.
31
−0
.0
4
0.
68
0.
14
3
0.
16
0.
13
2
0.
2
G
G
5
(4
.7
)
−0
.2
98
0.
00
2
−0
.2
65
0.
01
−0
.2
61
0.
00
8
0.
01
0.
92
0.
03
4
0.
74
A
A
+
G
A
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
G
G
−0
.2
8
0.
00
4
−0
.2
51
0.
01
−0
.2
56
0.
00
8
−0
.0
11
0.
91
0.
01
4
0.
89
C
Y
P
2E
1-
05
G
G
87
(8
1.
3)
0.
34
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
64
13
42
0
G
T
18
(1
6.
8)
−0
.1
73
0.
08
−0
.1
82
0.
08
−0
.1
85
0.
06
−0
.2
46
0.
01
−0
.2
03
0.
05
TT
2
(1
.9
)
0.
00
8
0.
94
−0
.0
12
0.
91
−0
.0
06
0.
95
−0
.0
11
0.
91
0.
03
1
0.
75
G
G
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
G
T
+T
T
−0
.1
6
0.
1
−0
.1
74
0.
09
−0
.1
76
0.
07
−0
.2
33
0.
02
−0
.1
84
0.
07
C
Y
P
3A
4-
02
A
A
10
2
(9
5.
3)
0.
8
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
27
40
57
4
G
A
5
(4
.7
)
0.
15
0.
13
0.
13
8
0.
18
0.
16
6
0.
09
0.
13
1
0.
18
0.
15
4
0.
12
M
P
O
-0
2
G
G
77
(7
2.
0)
0.
18
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
23
33
22
7
G
A
24
(2
2.
4)
0.
00
6
0.
95
0.
01
5
0.
88
0.
07
3
0.
47
−0
.0
72
0.
47
−0
.0
98
0.
33
A
A
6
(5
.6
)
0.
00
7
0.
95
0.
01
0.
93
0.
03
3
0.
74
−0
.0
15
0.
88
−0
.0
05
0.
96
(C
on
tin
ue
d)
Frontiers in Oncology | Cancer Epidemiology and Prevention February 2012 | Volume 2 | Article 14 | 8
Islami et al. Exposure to PAHs in Golestan, Iran
Ta
b
le
5
|C
o
n
ti
n
u
ed
Po
ly
m
o
rp
h
is
m
b
G
en
o
ty
p
e
N
o.
(%
)
P
W
in
te
r,
b
et
a-
co
ef
fi
ci
en
ts
S
u
m
m
er
,b
et
a-
co
ef
fi
ci
en
ts
fo
r
H
W
E
C
ru
d
e
β
P
-v
al
u
e
A
d
ju
st
ed
β
1
P
-v
al
u
e
A
d
ju
st
ed
β
2
P
-v
al
u
e
C
ru
d
e
β
P
-v
al
u
e
A
d
ju
st
ed
β
1
P
-v
al
u
e
P
H
A
S
E
II
E
N
Z
Y
M
E
S
G
ST
P
1-
01
A
A
64
(5
9.
3)
0.
02
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
16
95
G
A
37
(3
4.
2)
0.
09
2
0.
36
0.
09
9
0.
33
0.
05
1
0.
61
−0
.0
58
0.
57
−0
.0
67
0.
49
G
G
7
(6
.5
)
0.
08
5
0.
4
0.
11
0.
27
0.
12
2
0.
2
−0
.0
87
0.
39
−0
.1
64
0.
1
G
ST
P
1-
02
C
C
89
(8
2.
4)
0.
34
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
11
38
27
2
C
T
18
(1
6.
7)
−0
.0
34
0.
73
−0
.0
07
0.
95
−0
.0
27
0.
78
−0
.1
97
0.
04
−0
.2
13
0.
03
TT
1
(0
.9
)
−0
.0
57
0.
56
−0
.0
63
0.
52
−0
.0
5
0.
6
−0
.0
51
0.
6
−0
.0
57
0.
55
C
C
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
C
T
+T
T
−0
.0
45
0.
65
−0
.0
19
0.
85
−0
.0
36
0.
71
−0
.2
02
0.
04
−0
.2
18
0.
03
G
ST
M
1-
02
+
56
(5
1.
9)
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
E
x4
+
10
+
>
−
N
ul
l
52
(4
8.
1)
0.
14
8
0.
13
0.
11
9
0.
23
0.
08
1
0.
41
0.
21
7
0.
03
0.
19
8
0.
04
G
ST
T1
-0
2
+
19
(1
7.
6)
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
E
x5
-4
9
+
>
−
N
ul
l
89
(8
2.
4)
0.
20
3
0.
04
0.
26
8
0.
00
9
0.
22
8
0.
02
0.
07
6
0.
44
0.
05
5
0.
58
N
AT
2-
02
G
G
89
(8
2.
4)
0.
34
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
17
99
93
1
G
A
18
(1
6.
7)
0.
10
7
0.
28
0.
11
6
0.
24
0.
06
4
0.
5
−0
.0
85
0.
39
−0
.0
85
0.
46
A
A
1
(0
.9
)
0.
04
2
0.
67
0.
04
6
0.
64
0.
03
7
0.
7
0.
08
0.
42
−0
.0
84
0.
38
N
AT
2-
06
TT
52
(4
8.
1)
0.
00
3
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
18
01
28
0
C
T
45
(4
1.
7)
−0
.1
35
0.
28
−0
.0
85
0.
41
−0
.0
68
0.
5
0.
13
4
0.
19
0.
17
7
0.
08
C
C
11
(1
0.
2)
−0
.0
37
0.
72
−0
.0
77
0.
44
0.
01
6
0.
87
−0
.0
5
0.
62
−0
.0
35
0.
72
N
AT
2-
08
G
G
50
(4
6.
3)
0.
00
1
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
R
ef
er
en
ce
–
rs
17
99
93
0
G
A
50
(4
6.
3)
−0
.1
02
0.
31
−0
.0
88
0.
57
−0
.0
96
0.
33
−0
.0
13
0.
9
−0
.0
24
0.
81
A
A
8
(7
.4
)
0.
09
7
0.
34
0.
06
9
0.
51
0.
06
4
0.
53
0.
08
1
0.
43
−0
.0
58
0.
59
a
B
et
a-
co
ef
ﬁc
ie
nt
s
an
d
P
-v
al
ue
s
co
m
e
fr
om
lin
ea
r
re
gr
es
si
on
m
od
el
s,
in
w
hi
ch
cr
ea
tin
in
e-
ad
ju
st
ed
1-
O
H
P
G
le
ve
li
n
lo
ga
rit
hm
ic
sc
al
e
w
as
th
e
de
pe
nd
en
t
va
ria
bl
e.
A
dj
us
te
d
β
1:
re
su
lts
w
er
e
ad
ju
st
ed
fo
r
ag
e
(c
on
-
tin
uo
us
),
pl
ac
e
of
re
si
de
nc
e
(u
rb
an
;r
ur
al
),
et
hn
ic
ity
(n
on
-T
ur
km
en
;T
ur
km
en
),
bo
dy
m
as
s
in
de
x
(k
g/
m
2
,l
og
ar
ith
m
ic
sc
al
e)
,a
nd
fr
eq
ue
nc
y
of
ex
po
su
re
to
se
co
nd
-h
an
d
sm
ok
e
ov
er
th
e
pr
ev
io
us
24
h
(n
on
e;
1–
2;
≥3
ci
ga
re
tt
es
/d
ay
)i
n
th
e
re
sp
ec
tiv
e
se
as
on
.A
dj
us
te
d
β
2:
re
su
lts
fr
om
w
in
te
r
w
er
e
ad
di
tio
na
lly
ad
ju
st
ed
fo
r
re
d
m
ea
t
(n
on
e;
1–
24
;≥
25
g)
an
d
pr
oc
es
se
d
m
ea
t
(n
o
us
e,
an
y
us
e)
co
ns
um
pt
io
n
ov
er
th
e
pr
ev
io
us
24
-h
.
b T
he
w
ild
-t
yp
e
ge
no
ty
pe
is
sh
ow
n
as
re
fe
re
nc
e
gr
ou
p
in
th
e
ﬁr
st
ro
w
fo
r
ea
ch
po
ly
m
or
ph
is
m
.P
ol
ym
or
ph
is
m
s
ar
e
pr
es
en
te
d
ac
co
rd
in
g
to
S
N
P
50
0C
an
ce
r
an
d
S
in
gl
e
N
uc
le
ot
id
e
Po
ly
m
or
ph
is
m
D
at
ab
as
e
(d
bS
N
P
)
no
m
en
cl
at
ur
es
.F
or
G
ST
M
1-
02
an
d
G
ST
M
1-
02
,S
N
P
re
gi
on
s
ar
e
sh
ow
n,
be
ca
us
e
fo
r
th
em
no
db
S
N
P
in
fo
rm
at
io
n
is
av
ai
la
bl
e.
1-
O
H
P
G
,1
-h
yd
ro
xy
py
re
ne
gl
uc
ur
on
id
e;
B
et
a-
co
ef
f.,
B
et
a-
co
ef
ﬁc
ie
nt
;C
r,
cr
ea
tin
in
e;
H
W
E
,H
ar
dy
–W
ei
nb
er
g
eq
ui
lib
riu
m
.F
or
th
e
fu
ll
na
m
es
of
ge
ne
s,
se
e
S
ec
tio
n
“M
at
er
ia
ls
an
d
M
et
ho
ds
.”
www.frontiersin.org February 2012 | Volume 2 | Article 14 | 9
Islami et al. Exposure to PAHs in Golestan, Iran
Table 6 | Examples of 1-OHPG levels assessed with the same methodology in different studiesa.
Study; country Smoking status No. Mean (SD) Study participants
CRUDE 1-OHPG
Current study; Golestan Province,
Iran
Never-smoker (winter) 108 1.87 (2.70) Healthy women
Never-smoker (summer) 109 3.70 (3.98)
Kamangar et al. (2005); Golestan
Province, Iran
Never-smoker 49 3.7 (NA)b Healthy individuals
Former-smoker 20 2.7 (NA)b
Current-smoker 30 6.9 (NA)b
Fagundes et al. (2006); Brazil Non-smoker 103 1.14 (NA)b Healthy individuals
Smoker 96 3.76 (NA)b
Vineis et al. (1996); Italy Non-smoker 50 0.55 (0.05) Healthy men
Smoker 49 ∼1.05 (0.20)c
Kang et al. (1995); USA Non-smoker 10 0.23 (0.11) Healthy men, after 2weeks free of
charbroiled or smoked foods
Non-smoker 10 6.5 (1.5) Healthy men, the day after eating
225 g charbroiled meat
Gunier et al. (2006); USA Did not smoke in last 24 h 299 0.16 (NA)b Healthy female school teachers or
administrators
Smoked in last 24 h 5 1.61 (NA)b
Did not smoke but ate grilled meat in last 24 h 134 0.25 (NA)b
Neither smoked nor ate grilled meat in last 24 h 165 0.06 (NA)b
Cr-ADJUSTED 1-OHPG
Current study; Golestan Province,
Iran
Never-smoker (winter) 108 0.15 (0.17) Healthy women
Never-smoker (summer) 109 0.21 (0.31)
Lai et al. (2005); Taiwan Non-smoker 16 0.07 (0.04) Healthy ofﬁce worker women
Smoker 8 0.18 (0.07)
Non-smoker 42 0.16 (0.10) Healthy female highway toll station
workers
Smoker 5 0.12 (0.07)
Lee et al. (2003); South Korea Non-smoker 53 1.14 (NR) Healthy painters in a shipyard
Smoker 122 1.96 (NR)
Lee et al. (2002); South Korea Non-smoker 8 0.12 (0.03) Healthy administrative employes in an
industrial waste incinerating site
Smoker 10 0.21 (0.07)
Non-smoker 5 0.09 (0.04) Healthy waste incineration workers
Smoker 20 0.28 (0.09)
aCrude 1-OHPG and Cr-adjusted 1-OHPG levels are presented in pmol/ml urine and mol/molCr, respectively.
bMedians were presented.
cSmokers were divided to two groups; 1-OHPG level was 1.0 (SD 0.15) in ﬂue-cured tobacco users (n=31) and 1.1 (SD 0.23) in air-cured tobacco smokers (n=16).
1-OHPG, 1-hydroxypyrene glucuronide; Cr, creatinine; NA, not applicable; NR, not reported.
PAHs, so the level may not be an optimal indicator of exposure to
PAHs from fried food in general rather than in the previous few
hours. This fact and also the association between red meat intake
and 1-OHPG level suggests that fried red meat may be an impor-
tant source of PAH among those who use this food in Golestan,
although the association for fried redmeat did not reach statistical
signiﬁcance in our study. Frying has been shown to increase the
PAH content of foods; for example, in a study in Spain, the total
PAH content of raw lamb increased from 5.5μg/kg fresh weight to
16.9μg/kg after frying (Perello et al., 2008). In our study, the asso-
ciation between BMI and 1-OHPG level in winter may be related
to food intake, because the association was disappeared following
adjustments for other factors, including red meat intake.
Making bread at home in summer showed an association with
1-OHPG levels. On the other hand, there was no association
between 1-OHPG and making bread at home in winter. The fuel
used for making bread in both seasons was natural gas, so it is not
clear why such a practice was associatedwith increased exposure to
PAHs in only one round of our study. Some possible explanations
may be that the association is due to chance or that making bread
at home is a proxy for another habit or practice which is associated
with higher exposure to PAHs in summer than in winter.
Only a limited number of studies have investigated the associ-
ation between second-hand smoke and PAHs or their metabolites
in urine (Scherer et al., 1992; Suwan-Ampai et al., 2009). A recent
large study reported that elevated urinary concentrations of most
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PAH metabolites are associated with exposure to second-hand
smoke (Suwan-Ampai et al., 2009). Our ﬁndings also suggest a
similar association in both seasons, although the association in
winter was weaker than in summer. Our small sample size may
be one of the reasons for not observing a statistically signiﬁcant
association in winter. There was no increase in 1-OHPG levels
with exposure to tobacco smoke from one or two cigarettes; this
amount of exposure might not be sufﬁcient to increase 1-OHPG
levels in urine.
Phase I enzymes in the metabolic pathways of PAHs, including
CYPs and MPO, usually catalyze PAHs to more reactive metabo-
lites. Phase II enzymes, such as GSTs, catalyze the conjugation of
PAHs or their reactive metabolites to compounds that are more
water-soluble, so that they are more readily excreted (Chen et al.,
2007). Several studies have investigated the association between
polymorphisms in genes encoding the above enzymes and levels
of PAH metabolites in urine, but the results have not been very
consistent (Alexandrie et al., 2000; Schoket et al., 2001; Apostoli
et al., 2003; Abnet et al., 2007; Chen et al., 2007; Chuang and
Chang, 2007; Petchpoung et al., 2011). In our study, polymor-
phisms in some CYP genes were associated with lower levels of
1-OHPG, while deletions in GSTM1 and GSTT1 were associated
with elevated levels. However, except for CYP2E1-05, the other
polymorphisms did not show a consistent pattern in winter and
summer. The signiﬁcance and repeatability of these ﬁndings need
to be examined in further studies.
While the Caspian Littoral region in general is a humid area, the
areas with highest incidence of ESCC in Golestan have a relatively
dry climate (Mahboubi, 1971). The urine samples collected inwin-
ter were more diluted than summer urine, which may be related
to greater dehydration of inhabitants in Golestan in summer than
in winter. From a methodological point of view, this suggests the
importance of adjustment for creatinine levels when a single spot
urine sample is analyzed for PAH metabolites. Different patterns
of association in the winter and summer rounds in our study, e.g.,
with regard to BMI, suggest exposure to different sources of PAH
in different seasons in Golestan. These potential variations should
also be considered in future investigations.
Our study has strengths and limitations.We collected extensive
questionnaire data, which allowed us to examine the associations
of interest while considering the inﬂuence of several other lifestyle-
related factors. We collected samples in two seasons to reduce the
effect of inter-individual and seasonal variations. However, not
having 24-h food intake data in the second round (summer) did
not allow us to compare the pattern of exposure to PAHs in the
two seasons with regard to diet and to adjust the analyses in the
summer for diet. Furthermore,multiple comparisonswere done in
our analyses. Therefore, some of the statistically signiﬁcant results
might have arisen by chance. However, at least regarding exposure
to red meat intake, the results seem to be robust.
In summary, the study conﬁrms high exposure to PAHs of the
general population in Golestan, which does not seem to be related
to heating in winter, and for which certain foods may be impor-
tant factors among individuals who consume those foods. With
regard to esophageal cancer, it is possible that drinking hot tea,
a habit common in Golestan, exposes esophageal cells to higher
amounts of ingested PAHs than in individuals who drink their
tea at moderate temperatures (Islami et al., 2009a,c). Exposure
to second-hand tobacco smoke also showed an association with
PAHs, but the prevalence of the exposure was low. Although high-
temperature frying is a common cooking practice in Golestan,
approximately 50% of participants in our study did not consume
red meat in the previous 24 h. We were not able to identify the
factors explaining the high levels of PAH in all participants, sug-
gesting that there is no single factor responsible for this pattern
in our study population and, very likely, in Golestan. The poten-
tial differences in pattern of exposure in summer and winter also
points to variability of major sources of PAHs. Results of this pilot
study may be helpful in determining the issues to be focused on
in future studies, e.g., PAH content in fried foods and potential
seasonal variation in sources of PAHs. Further studies on bio-
markers of internal exposure (e.g., PAH-related DNA adducts)
and on the potential association of exposure to PAHs and risk
of esophageal cancer are also warranted. Due to possible asso-
ciations of exposure to ingested PAHs with several other health
outcomes, including cancer of the urinary bladder and cardio-
vascular diseases (Curfs et al., 2005; Ramos and Moorthy, 2005;
Baan et al., 2009), the beneﬁts of identifying and avoiding the
preventable exposures to PAHs in the general population may go
beyond esophageal cancer.
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APPENDIX
DETAILS OF LABORATORY ASSESSMENTS
Assessment of 1-hydroxypyrene glucuronide (1-OHPG)
In order to hydrolyze acid-labile conjugated metabolites, each
urine sample was treated with 1N HCl at 90˚C for 1 h. Under
these hydrolysis conditions, 1-OHPG is stable. Then, 1-OHPG
was loaded on methanol/water primed Sep-Pak C18 cartridges
(Waters, Milford, MA, USA). After being washed with water and
30% methanol in water, the samples were eluted by the same vol-
ume of 80%methanol in water.With mild heating under vacuum,
the eluate was concentrated to approximately one-eighth of the
initial volume. Adding 7.5mM phosphate-buffered saline (PBS),
with pH 7.4, the volume was increased to 4ml. The samples were
loaded on immunoafﬁnity columns containing CNBr-activated
Sepharose 4B conjugated with monoclonal antibody 8E11 which
recognizes 1-OHPG. Then the samples were washed with 7.5mM
PBS and 25% methanol in 7.5mM PBS, and 1-OHPG was eluted
with 70% methanol in 7.5mM PBS. The samples were dried and
re-dissolved in 2ml of water. The 1-OHPG content of the sam-
ples was measured with synchronous ﬂuorescence spectroscopy
(Perkin Elmer LS50B Luminescence spectrometer, Norwalk, CT,
USA) using a wavelength difference of 34 nm between excitation
and emission. The limit of detection was 0.01 ng 1-OHPG/ml
urine and the recovery of the assay was 95–100%. The adjustment
of 1-OHPG levels for creatinine was done as following:
Creatinine(mg/dl) × 0.0884 = creatinine(μmol/ml)
Cr - adjusted 1 - OHPG ( mol/molCr) = 1 - OHPG (pmol/ml)/
creatinine (μmol/ml)
Genotyping
DNA was isolated by standard phenol extraction proce-
dures and PCR was done as reported previously(Knaapen
et al., 2004) in two multiplex PCR reactions. The multi-
plexes included the following polymorphisms; series A: CYP1A2-
03 (rs762551), NAT2-02 (rs1799931), NAT2-06 (rs1801280),
NAT2-08 (rs1799930),GSTM1-02 (deletion),GSTP1-01 (rs1695),
GSTP1-02 (rs1138272), and GSTT1-02 (deletion); series B:
CYP1A1-01 (rs1048943), CYP1A1-03 (rs1799814), CYP1B1-05
(rs1056836), CYP1B1-07 (rs1800440), CYP2E1-05 (rs6413420),
CYP3A4-02 (rs2740574), and MPO-02 (rs2333227). PCR was
carried out in a Tgradient 96-well Thermal cycler (Biometra,
Goettingen, Germany) in a 10-μl volume, containing PCR buffer
(Invitrogen, Breda, the Netherlands), 0.2mmol/l deoxynucleotide
triphosphates (Invitrogen), 1.75mmol/l MgCl2 (Invitrogen), 0.25
unit Platinum Taq-Polymerase (Invitrogen), and 40 ng template
DNA. The ﬁnal concentration of the primers was 0.2μmol/l. PCR
conditions were: denaturation at 94˚C for 3min; 30 cycles of 94˚C
for 30 s, 56˚C (series A)/60˚C (series B) for 30 s, and 72˚C for 30 s;
and aﬁnal extension at 72˚C for 5min.The sampleswere incubated
at 37˚C (45min) with 4μl Exo-SAP-IT (Amersham, Roosendaal,
the Netherlands) to degrade deoxynucleotide triphosphates and
PCR primers. The enzymes were deactivated at 75˚C (15min).
Genotyping was performed by single base extension (SBE)
method using SnaPShot (Applied Biosystems, Nieuwerkerk, a.d.
IJssel, the Netherlands), and primer 3 and Netprimer software
were used to design SBE primers. Following SBE, the samples
were incubated at 37˚C (1 h) with 1 unit shrimp alkaline phos-
phatase (Amersham) to degrade the unincorporated dideoxynu-
cleotide triphosphates. Twomultiplex genotyping experiments (as
described above) were used for SBE reactions. SBE products were
diluted and mixed with deionized formamide containing Genes-
can 120 LIZ size standard. The mixture was denatured at 95˚C for
5min. Finally, the samples were analyzed on an ABI Prism 3100
genetic analyser using Genescan Analysis software.
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